1. Du Xiaoxi, Zhang Chengxu, Guo Huipu, et al. Adverse drug reactions monitoring and supervision. Beijing: China Medical Science Press; 2013.
2. China Food and Drug Administration. Provisions for adverse drug reaction reporting and monitoring. 2004. http://www.sda.gov.cn/WS01/CL0053/24477.html . Accessed 19 July 2016.
3. Ministry of Health. Provisions for Adverse Drug Reaction Reporting and Monitoring. 2011. http://www.nhfpc.gov.cn/mohzcfgs/pgz/201105/51770.shtml . Accessed 19 July 2016.
4. China Food and Drug Administration. Provisions for drug registration. 2007. http://www.sda.gov.cn/WS01/CL0053/24529.html . Accessed 19 July 2016.
5. National Health and Family Planning Statistics Information Center. Number of medical institutions nationwide. 2015. http://www.nhfpc.gov.cn/mohwsbwstjxxzx/s7967/201501/1e39cfd2159d426c8e46e29280dbd7f9.shtml . Accessed 19 July 2016.